Skip to main content

Day: October 21, 2024

Sify Technologies Ltd. Regains Compliance with Nasdaq Minimum Bid Price Requirement

CHENNAI, India, Oct. 21, 2024 (GLOBE NEWSWIRE) — Sify Technologies Ltd. (Nasdaq: Sify) (the “Company”), a leading integrated information communications technology (or ICT) Solutions and Services provider in India, received a letter (the “Notification Letter”) from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) on October 18, 2024, informing the Company that it has regained compliance with the minimum bid price requirement for continued listing set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”) and the matter is closed. As announced in July 2024, the Company was notified by Nasdaq that it was not in compliance with the Minimum Bid Price Requirement, as the closing bid price of the Company’s American Depositary Shares (“ADSs”) had been below $1.00 for 30...

Continue reading

Live Oak Ventures Participates in Financing of Synply, Inc.

WILMINGTON, N.C., Oct. 21, 2024 (GLOBE NEWSWIRE) — Live Oak Ventures, the investment arm of Live Oak Bancshares, Inc., has announced an investment in Synply Inc., a cloud-based technology company dedicated to transforming the loan syndication process for banks. “Live Oak’s entrepreneurial environment is fertile ground for new and exciting companies like Synply to enter the fintech landscape,” said Stephanie Mann, Live Oak Bank Chief Strategy Officer. “After incubating the Synply platform at Live Oak, we are excited to see the company level the playing field for all banks to compete in the syndicated loan space.” Synply offers banks a simplified tool to centralize the entire process of syndicated lending and portfolio management. “We built Synply because we saw a critical need for a modern and intuitive platform specifically designed...

Continue reading

Real Matters to Announce Fourth Quarter and Fiscal 2024 Financial Results on November 21, 2024

TORONTO, Oct. 21, 2024 (GLOBE NEWSWIRE) — Real Matters Inc. (“Real Matters”), a leading network management services provider for the mortgage lending and insurance industries, will announce its fourth quarter and fiscal 2024 financial results via news release on Thursday, November 21, 2024, before market open. Conference Call and Webcast         A conference call to review the results will take place at 10:00 a.m. (ET) on Thursday, November 21, 2024, hosted by Chief Executive Officer Brian Lang and Chief Financial Officer Rodrigo Pinto. An accompanying slide presentation will be posted to the Investor Relations section of our website shortly before the call. To access the call:Participant Local (Toronto): (416) 764-8624 Participant Toll Free Dial-In Number: (888) 259-6580 Conference ID: 77493257To listen to the live webcast...

Continue reading

WTW Launches Structured Auto Buffer London Excess Facility to transform fleet risk management

NEW YORK, Oct. 21, 2024 (GLOBE NEWSWIRE) — WTW (Nasdaq: WTW), a leading global advisory, broking, and solutions company, announced the launch of its new Structured Auto Buffer London Excess (StABLE) facility, providing an innovative risk financing solution through ‘Swing Plan’ structures. This new offering is an innovative dedicated structured Auto Liability solution in the marketplace that supports organizations with managing fleet risks while rewarding them for comprehensive risk management practices and favorable loss performance. The WTW StABLE facility enables clients to share in both the risk and reward of their fleet operations. If losses remain below a predetermined threshold, clients may receive some returned premium, with an option to commute the policy for additional returns. If losses exceed the threshold, additional...

Continue reading

New employee-elected board member

Company announcement No. 42 Anne Breum, one of the employee-elected members of the Board of Directors of Novozymes A/S, part of Novonesis Group (the “Company”), has decided to step down as a board member. The first alternate, Lena Bech Holskov (Safety Adviser, OHS) has replaced Anne Breum as employee-elected board member of the Company for the remaining period of the current four-year election term ending following the annual general meeting of the Company to be held on April 3, 2025. Cees de Jong, Chair of the Board of Directors of the Company, comments: “On behalf of the Board of Directors and the Company, I’d like to thank Anne for her dedicated contribution to the Company and the Board of Directors.”Attachment2024_42_New employee-elected board member

Continue reading

Biomea Fusion Announces Approval of “icovamenib” as International Nonproprietary Name for BMF-219

Icovamenib is an oral covalent menin inhibitor in clinical development to investigate its impact on the function of insulin-producing beta cells REDWOOD CITY, Calif., Oct. 21, 2024 (GLOBE NEWSWIRE) — Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage biopharmaceutical company dedicated to discovering and developing oral covalent small molecules to treat and improve the lives of patients with diabetes, obesity, and genetically defined cancers, today announced that the World Health Organization (WHO) has approved “icovamenib” as the International Nonproprietary Name (INN) for its lead product candidate BMF-219, and that the United States Adopted Name Council has adopted “icovamenib” as the United States Adopted Name (USAN) for BMF-219. The suffix ‘-menib’ stands for menin inhibitor. An International Nonproprietary Name...

Continue reading

UPDATE – Grab to Announce Third Quarter 2024 Results on November 11, 2024

NEW YORK, Oct. 21, 2024 (GLOBE NEWSWIRE) — Grab Holdings Limited (NASDAQ: GRAB, the “Company”  or “Grab”), plans to announce its unaudited third quarter 2024 results after the U.S. market closes on November 11, 2024.   The Company’s management will hold a conference call to discuss the third quarter 2024 results at:Date and time: 7:00 PM U.S Eastern Time on November 11, 20248:00 AM Singapore Time on November 12, 2024A link to the call will be posted on the Company’s investor relations website at investors.grab.com prior to the call time.  Following the call, a replay of the call, along with the earnings press release and presentation slides, will be available at the same website. About Grab Grab is a leading superapp in Southeast Asia, operating across the deliveries, mobility and digital financial services sectors. Serving...

Continue reading

Andres Kitter, Board Member of LHV Bank, to step down

Andres Kitter, Chief Technology Officer and a member of the executive committee and board of LHV Bank Limited, a subsidiary of LHV Group operating in the United Kingdom, will step down from his position at the end of this year. Andres Kitter joined LHV in 2013 as a member of the management board of LHV Bank and Head of Retail Banking. Under his leadership, the retail banking offering in Estonia was developed, the business line for international financial intermediaries was launched, and LHV was established in the UK. In his role as Chief Technology Officer, Andres Kitter built one of the most modern banking platforms and assembled a strong team. “The profitable business line of servicing financial intermediaries, developed under Andres’ initiative and leadership, has helped expand both LHV’s mental and operating landscape....

Continue reading

Innocan Pharma to Present at the 2024 ThinkEquity Conference

HERZLIYA, Israel and CALGARY, Alberta, Oct. 21, 2024 (GLOBE NEWSWIRE) — Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (“Innocan” or the “Company”), a pioneer in chronic pain management via Liposomal CBD drug products, today announced that it will be participating in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. The ThinkEquity Conference gathers institutional investors, corporate clients, and other industry professionals to highlight groundbreaking innovations and financial strategies. In addition, the Company will be discussing its recently achieved significant regulatory milestones, in particular, securing a U.S. Food and Drug Administration (FDA) approval for a 505(2)(b) abbreviated pathway for its human health applications. This included...

Continue reading

Boralex will release its 2024 third quarter financial results on November 14

MONTREAL, Oct. 21, 2024 (GLOBE NEWSWIRE) — Boralex inc. (“Boralex” or the “Company”) (TSX: BLX) announces that the release of the 2024 third quarter results will take place on Thursday, November 14, 2024, at 11 a.m. Financial analysts and investors are invited to attend a conference call during which the financial results will be presented. Date and time Thursday, November 14, 2024, at 11 a.m. To attend the conference Webcast link: https://edge.media-server.com/mmc/p/mr7srj6t To attend the event by phone: Click here to register for the earnings call. Once you have completed your registration, you will receive a confirmation email containing the link and your personal PIN to connect to the call. If you lose this link and your PIN, you will be able to register again. You must register if you wish to attend the call by phone. Media...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.